Zimmer Biomet Holdings Inc (ZBH)

NYSE
Currency in USD
90.21
-1.95(-2.12%)
Closed·
Pre Market
90.210.00(0.00%)
·
ZBH Scorecard
Full Analysis
Management has been aggressively buying back shares
ZBH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
90.0991.99
52 wk Range
89.22116.71
Key Statistics
Edit
Prev. Close
90.21
Open
91.23
Day's Range
90.09-91.99
52 wk Range
89.22-116.71
Volume
1.68M
Average Vol. (3m)
2.24M
1-Year Change
-15.72%
Book Value / Share
62.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZBH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
107.50
Upside
+19.17%
Members' Sentiments
Bearish
Bullish
ProTips
17 analysts have revised their earnings downwards for the upcoming period

Zimmer Biomet Holdings Inc News & Analysis

Show more

Zimmer Biomet Holdings Inc Company Profile

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Zimmer Biomet Holdings Inc SWOT Analysis


Future Prospects
Delve into ZBH's Long Range Plan targeting mid-single-digit revenue growth and EPS growth at 1.5x revenue rate, amid market challenges and opportunities
Strategic Expansion
Explore Zimmer Biomet's $1.1B acquisition of Paragon 28, positioning the company in the $5B Foot & Ankle Orthopedics market for diversified growth
Financial Resilience
Despite ERP implementation hurdles, ZBH reports $1.82B Q3 sales. Analysts set price targets ranging from $101 to $140, with an average around $125
Orthopedic Innovato
Zimmer Biomet navigates challenges while maintaining mid-single-digit growth, leveraging a robust product pipeline including ROSA Shoulder and new knee implants
Read full SWOT analysis

Zimmer Biomet Holdings Inc Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of $1.81 beat expectations, but stock fell 8.12% to $102.38 amid investor concerns over YoY EPS decline
  • Revenue grew 1.1% YoY to $1.91B; company reaffirmed 3-5% organic constant currency revenue growth guidance for 2025
  • Anticipated $60-80M tariff headwinds in 2025; management confident in offsetting EPS dilution from tariffs and acquisitions
  • ASC market growth and Paragon 28 acquisition highlighted as key revenue drivers; inventory management remains a challenge
  • InvestingPro analysis suggests stock undervaluation with $18.64B market cap and 10.2x EV/EBITDA ratio
Last Updated: 05/05/2025, 09:57 AM
Read Full Transcript

Compare ZBH to Peers and Sector

Metrics to compare
ZBH
Peers
Sector
Relationship
P/E Ratio
19.5x−12.4x−0.4x
PEG Ratio
−8.470.000.00
Price / Book
1.4x3.2x2.6x
Price / LTM Sales
2.3x2.4x3.0x
Upside (Analyst Target)
14.0%73.5%52.3%
Fair Value Upside
Unlock3.7%9.4%Unlock

Analyst Ratings

10 Buy
17 Hold
2 Sell
Ratings:
29 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 107.50
(+19.17% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.53%
Dividend Yield
1.06%
Industry Median 0.75%
Annualized Payout
0.96
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 05, 2025
EPS / Forecast
1.81 / 1.77
Revenue / Forecast
1.91B / 1.89B
EPS Revisions
Last 90 days

ZBH Income Statement

People Also Watch

169.94
BDX
-1.26%
160.56
STZ
-1.38%
98.72
PHM
-3.61%
373.37
SYK
-0.99%
52.94
ON
-1.74%

FAQ

What Is the Zimmer Biomet (ZBH) Stock Price Today?

The Zimmer Biomet stock price today is 90.21

What Stock Exchange Does Zimmer Biomet Trade On?

Zimmer Biomet is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Zimmer Biomet?

The stock symbol for Zimmer Biomet is "ZBH."

Does Zimmer Biomet Pay Dividends? What’s The Current Dividend Yield?

The Zimmer Biomet dividend yield is 1.06%.

What Is the Zimmer Biomet Market Cap?

As of today, Zimmer Biomet market cap is 17.85B.

What Is Zimmer Biomet's Earnings Per Share (TTM)?

The Zimmer Biomet EPS (TTM) is 4.53.

When Is the Next Zimmer Biomet Earnings Date?

Zimmer Biomet will release its next earnings report on Aug 05, 2025.

From a Technical Analysis Perspective, Is ZBH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Zimmer Biomet Stock Split?

Zimmer Biomet has split 0 times.

How Many Employees Does Zimmer Biomet Have?

Zimmer Biomet has 17000 employees.

What is the current trading status of Zimmer Biomet (ZBH)?

As of Jun 18, 2025, Zimmer Biomet (ZBH) is trading at a price of 90.21, with a previous close of 90.21. The stock has fluctuated within a day range of 90.09 to 91.99, while its 52-week range spans from 89.22 to 116.71.

What Is Zimmer Biomet (ZBH) Price Target According to Analysts?

The average 12-month price target for Zimmer Biomet is USD107.5, with a high estimate of USD130 and a low estimate of USD91. 10 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +19.17% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.